JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'ms 275'

Search results for: 'ms 275'

B5540 MS 245 oxalate

Summary: 5-HT6 antagonist

Soluble in DMSO
B5307 CH 275

Summary: Potent somatostatin receptor 1 (sst1) agonist

Soluble to 0.30 mg/mL
A8171 Entinostat (MS-275,SNDX-275)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC1 and HDAC3 inhibitor

insoluble in H2O; ≥18.8 mg/mL
B1426 Org 27569

Target: CB1 Receptors

Summary: Cannabinoid CB1 receptor allosteric modulator

insoluble in H2O; ≥13.95 mg/mL
B6996 Ro 08-2750

Summary: antagonist of nerve growth factor (NGF)

≤2.7 mg/mL
B7346 PF 915275

Summary: 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) inhibitor

Soluble in DMSO
F1704 Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab)

Summary: Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab)
BA5309 GSK682753A

Summary: GSK682753A is an inverse agonist of EBV-inducible receptor 2.
BA6721 PF-03463275

Summary: PF-03463275 is a CNS-permeable, orally active, selective, competitive reversible inhibitor of glycine transporter protein-1.
BA4360 RBN012759

Summary: RBN012759 is a potent, selective and orally active inhibitor with values <3nM, 300-fold more selective than for monoPARPs and 1000-fold more selective than for polyPARPs.